Today we are at the stage of development of medical science when we can safely say that personalized treatment is at the heart of global oncology.
Unlike the cancer treatment standards that have been applied in our country for the past 15 years, the principle of an individual approach or personalization in cancer treatment has long been used in economically developed countries. The principle of "one technology, or one medicine for all" goes down in history. The fact is that almost every tumor has some kind of "breakage" of genes, recognizing which it is possible to target a specific receptor. This leads to the death of the cancer cell.
The essence of the approach is that different types of genetic tests should be performed for different types of cancer. For example, if a patient with lung cancer or breast cancer has a mutation of a certain gene, then for an experienced oncologist this is a signal to prescribe treatment with a certain drug with proven effectiveness, allowing in this particular case to achieve the best cure rates. And if there is no such mutation, then the treatment will be different.
Patients who are faced with such a problem can receive this targeted diagnosis and treatment at the European Medical Center, where the campaign "Second opinion in oncology». Specialists of the Oncology and Hematology Clinic provide consultations on personalized cancer treatment.
Patients need a second or independent opinion to achieve several goals. First of all, so that the patient can freely navigate his diagnosis and his problem. Secondly, the patient can learn about the personalized approaches in the diagnosis and treatment of his disease that are used in Europe and North America. At the same time, you do not need to go to Germany or Israel for advice. Thirdly, you can get the opportunity to receive treatment using Western technologies and original drugs at a significant discount.
What is the difference between original drugs and generics? An original medicinal product is a medicine that is produced by the pharmaceutical company that developed the drug. When using the original drug, the doctor guarantees proven efficacy and safety when it comes to crippling treatment - chemotherapy.
Indeed, generics (drugs that are analogues of original medicines) are cheaper than the original. The reason is that their manufacturers do not spend money on their development or on clinical research. The differences may be in the quality of the substance of the active substance and in fillers.
The medicine consists not only of the active substance, but also of a filler. There are no requirements for excipients at all: therefore, it is unlikely that this cytostatic agent will have less toxicity. And the treatment of toxicity can be much more expensive than the antitumor treatment itself.
Therefore, EMC doctors recommend using original drugs.
All this suggests that cancer can and should be treated, and the chances of a complete cure are especially high in the early stages.
Was this information helpful?
Questions and answers
Ask a Question
.webp)
